1. Henaut L, Mary A, Chillon JM, Kamel S, Massy ZA. The Impact of Uremic Toxins on Vascular Smooth Muscle Cell Function. Toxins. 2018; 10.
2. Furusawa K, Takeshita K, Suzuki S, Tatami Y, Morimoto R, Okumura T, et al. Assessment of abdominal aortic calcification by computed tomography for prediction of latent left ventricular stiffness and future cardiovascular risk in pre-dialysis patients with chronic kidney disease: A single center cross-sectional study. International journal of medical sciences. 2019; 16: 939-48.
3. Sato B, Yoshikawa D, Ishii H, Kikuchi R, Arima T, Takeshita K, et al. Indoxyl sulfate, a uremic toxin, and carotid intima-media thickness in patients with coronary artery disease. International journal of cardiology. 2013; 163: 214-6.
4. Baeten JT, Lilly B. Notch Signaling in Vascular Smooth Muscle Cells. Advances in pharmacology. 2017; 78: 351-82.
5. Radtke F, Wilson A, Mancini SJ, MacDonald HR. Notch regulation of lymphocyte development and function. Nature immunology. 2004; 5: 247-53.
6. Takeshita K, Satoh M, Ii M, Silver M, Limbourg FP, Mukai Y, et al. Critical role of endothelial Notch1 signaling in postnatal angiogenesis. Circulation research. 2007; 100: 70-8.
7. Kikuchi R, Takeshita K, Uchida Y, Kondo M, Cheng XW, Nakayama T, et al. Pitavastatin-induced angiogenesis and arteriogenesis is mediated by Notch1 in a murine hindlimb ischemia model without induction of VEGF. Laboratory investigation; a journal of technical methods and pathology. 2011; 91: 691-703.
8. Li Y, Takeshita K, Liu PY, Satoh M, Oyama N, Mukai Y, et al. Smooth muscle Notch1 mediates neointimal formation after vascular injury. Circulation. 2009; 119: 2686-92.
9. Fischer A, Schumacher N, Maier M, Sendtner M, Gessler M. The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes & development. 2004; 18: 901-11.
10. Tamai H, Kobayashi M, Takeshita K, Kodama A, Banno H, Narita H, et al. Possible involvement of Notch signaling in the pathogenesis of Buerger's disease. Surgery today. 2014; 44: 307-13.
11. Shang Y, Smith S, Hu X. Role of Notch signaling in regulating innate immunity and inflammation in health and disease. Protein & cell. 2016; 7: 159-74.
12. Niwa T. Targeting protein-bound uremic toxins in chronic kidney disease. Expert opinion on therapeutic targets. 2013; 17: 1287-301.
13. Leopold JA. Vascular calcification: Mechanisms of vascular smooth muscle cell calcification. Trends in cardiovascular medicine. 2015; 25: 267-74.
14. Zamurovic N, Cappellen D, Rohner D, Susa M. Coordinated activation of notch, Wnt, and transforming growth factor-beta signaling pathways in bone morphogenic protein 2-induced osteogenesis. Notch target gene Hey1 inhibits mineralization and Runx2 transcriptional activity. The Journal of biological chemistry. 2004; 279: 37704-15.
15. Tang Z, Wei J, Yu Y, Zhang J, Liu L, Tang W, et al. gamma-Secretase inhibitor reverts the Notch signaling attenuation of osteogenic differentiation in aged bone marrow mesenchymal stem cells. Cell biology international. 2016; 40: 439-47.
16. Harrison OJ, Visan AC, Moorjani N, Modi A, Salhiyyah K, Torrens C, et al. Defective NOTCH signaling drives increased vascular smooth muscle cell apoptosis and contractile differentiation in bicuspid aortic valve aortopathy: A review of the evidence and future directions. Trends in cardiovascular medicine. 2019; 29: 61-8.
17. Garg V, Muth AN, Ransom JF, Schluterman MK, Barnes R, King IN, et al. Mutations in NOTCH1 cause aortic valve disease. Nature. 2005; 437: 270-4.
18. Adijiang A, Goto S, Uramoto S, Nishijima F, Niwa T. Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2008; 23: 1892-901.
19. Niwa T, Takeda N, Tatematsu A, Maeda K. Accumulation of indoxyl sulfate, an inhibitor of drug-binding, in uremic serum as demonstrated by internal-surface reversed-phase liquid chromatography. Clinical chemistry. 1988; 34: 2264-7.
20. Yisireyili M, Takeshita K, Hayashi M, Wu H, Uchida Y, Yamamoto K, et al. Dipeptidyl peptidase- IV inhibitor alogliptin improves stress-induced insulin resistance and prothrombotic state in a murine model. Psychoneuroendocrinology. 2016; 73: 186-95.
21. Aoyama T, Takeshita K, Kikuchi R, Yamamoto K, Cheng XW, Liao JK, et al. gamma-Secretase inhibitor reduces diet-induced atherosclerosis in apolipoprotein E-deficient mice. Biochemical and biophysical research communications. 2009; 383: 216-21.
22. Uchida Y, Takeshita K, Yamamoto K, Kikuchi R, Nakayama T, Nomura M, et al. Stress augments insulin resistance and prothrombotic state: role of visceral adipose-derived monocyte chemoattractant protein-1. Diabetes. 2012; 61: 1552-61.
23. Chen NX, O'Neill KD, Duan D, Moe SM. Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells. Kidney international. 2002; 62: 1724-31.
24. McCullough PA, Agrawal V, Danielewicz E, Abela GS. Accelerated atherosclerotic calcification and Monckeberg's sclerosis: a continuum of advanced vascular pathology in chronic kidney disease. Clinical journal of the American Society of Nephrology : CJASN. 2008; 3: 1585-98.
25. Lanzer P, Boehm M, Sorribas V, Thiriet M, Janzen J, Zeller T, et al. Medial vascular calcification revisited: review and perspectives. European heart journal. 2014; 35: 1515-25.
26. Billaud M, Hill JC, Richards TD, Gleason TG, Phillippi JA. Medial Hypoxia and Adventitial Vasa Vasorum Remodeling in Human Ascending Aortic Aneurysm. Frontiers in cardiovascular medicine. 2018; 5: 124.
27. Asai H, Hirata J, Hirano A, Hirai K, Seki S, Watanabe-Akanuma M. Activation of aryl hydrocarbon receptor mediates suppression of hypoxia-inducible factor-dependent erythropoietin expression by indoxyl sulfate. American journal of physiology Cell physiology. 2016; 310: C142-50.
28. Landor SK, Lendahl U. The interplay between the cellular hypoxic response and Notch signaling. Experimental cell research. 2017; 356: 146-51.
29. Garg V. Notch Signaling in Aortic Valve Development and Disease. In: Nakanishi T, Markwald RR, Baldwin HS, Keller BB, Srivastava D, Yamagishi H, editors. Etiology and Morphogenesis of Congenital Heart Disease: From Gene Function and Cellular Interaction to Morphology. Tokyo; 2016. p. 371-6.
30. Hilton MJ, Tu X, Wu X, Bai S, Zhao H, Kobayashi T, et al. Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation. Nature medicine. 2008; 14: 306-14.
31. Yao XX, Lu JB, Ye ZD, Zheng L, Wang Q, Lin ZQ, et al. Hairy/enhancer of Split Homologue-1 Suppresses Vascular Endothelial Growth Factor-induced Angiogenesis via Downregulation of Osteopontin Expression. 2017; 7: 898.
32. Wang H, Jiang Z, Zhang J, Xie Z, Wang Y, Yang G. Enhanced osteogenic differentiation of rat bone marrow mesenchymal stem cells on titanium substrates by inhibiting Notch3. Archives of oral biology. 2017; 80: 34-40.
33. Doi H, Iso T, Sato H, Yamazaki M, Matsui H, Tanaka T, et al. Jagged1-selective notch signaling induces smooth muscle differentiation via a RBP-Jkappa-dependent pathway. The journal of biological chemistry. 2006; 281: 28555-64.
34. High FA, Lu MM, Pear WS, Loomes KM, Kaestner KH, Epstein JA. Endothelial expression of the Notch ligand Jagged1 is required for vascular smooth muscle development. Proceedings of the National Academy of Sciences of the United States of America. 2008; 105: 1955-9.
35. Bosse K, Hans CP, Zhao N, Koenig SN, Huang N, Guggilam A, et al. Endothelial nitric oxide signaling regulates Notch1 in aortic valve disease. Journal of molecular and cellular cardiology. 2013; 60: 27-35.
36. Niwa T, Shimizu H. Indoxyl sulfate induces nephrovascular senescence. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation. 2012; 22: 102-6.
37. Zeng C, Xing R, Liu J, Xing F. Role of CSL-dependent and independent Notch signaling pathways in cell apoptosis. Apoptosis : an international journal on programmed cell death. 2016; 21: 1-12.
38. Gao H, Liu S. Role of uremic toxin indoxyl sulfate in the progression of cardiovascular disease. Life sciences. 2017; 185: 23-9.
39. Lehto S, Niskanen L, Suhonen M, Ronnemaa T, Laakso M. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arteriosclerosis, thrombosis, and vascular biology. 1996; 16: 978-83.